APA (7th ed.) Citation

Dunn, K. E., Bergeria, C. L., Huhn, A. S., Speed, T. J., Mun, C. J., Vandrey, R., & Campbell, C. M. (2021). Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model. Neuropsychopharmacology (New York, N.Y.), 46(8), 1451-1459. https://doi.org/10.1038/s41386-021-01007-4

Chicago Style (17th ed.) Citation

Dunn, Kelly E., Cecilia L. Bergeria, Andrew S. Huhn, Traci J. Speed, Chung Jung Mun, Ryan Vandrey, and Claudia M. Campbell. "Within-subject, Double-blinded, Randomized, and Placebo-controlled Evaluation of the Combined Effects of the Cannabinoid Dronabinol and the Opioid Hydromorphone in a Human Laboratory Pain Model." Neuropsychopharmacology (New York, N.Y.) 46, no. 8 (2021): 1451-1459. https://doi.org/10.1038/s41386-021-01007-4.

MLA (9th ed.) Citation

Dunn, Kelly E., et al. "Within-subject, Double-blinded, Randomized, and Placebo-controlled Evaluation of the Combined Effects of the Cannabinoid Dronabinol and the Opioid Hydromorphone in a Human Laboratory Pain Model." Neuropsychopharmacology (New York, N.Y.), vol. 46, no. 8, 2021, pp. 1451-1459, https://doi.org/10.1038/s41386-021-01007-4.